Study shows clinical benefit of new way of tr : comparemela.

<p>A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor has anti-tumour effects in oestrogen receptor positive breast cancer patients.</p>

Related Keywords

Carlo Palmieri , Beth Overmoyer , Clatterbridge Cancer Centre , Method Of Research , Dana Farber Cancer Institute Of Boston United States , University Of Liverpool , Lancet Oncology , Professor Carlo Palmieri , Nature Medicine , Dana Farber Cancer Institute , Boston United States ,